Vaccination protects 2 microglobulin deficient mice from immune mediated mortality but not from persisting viral infection

By Hildeman D.   Salvato M.   Whitton J.L.   Muller D.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1223-1229

Elsevier

Access to resources Recommend Favorite

Viral Pathogens and Severe Acute Respiratory Syndrome: Oligodynamic Ag⁺ for Direct Immune Intervention

By Rentz Do Comm Cnmo Eric  

Journal of Nutritional & Environmental Medicine, Vol. 13, Iss. 2, 2003-06 ,pp. : 109-118

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the efficacy of early versus late viral proteins in vaccination against SIV

By Stittelaar K.J.   Gruters R.A.   Schutten M.   van Baalen C.A.   van Amerongen G.   Cranage M.   Liljestrom P.   Sutter G.   Osterhaus A.D.M.E.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 2921-2927

Elsevier

Access to resources Recommend Favorite

Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response

By Johansson B.E.   Matthews J.T.   Kilbourne E.D.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 1009-1015

Elsevier

Access to resources Recommend Favorite

Association of bovine DRB3 alleles with immune response to FMDV peptides and protection against viral challenge

By Garca-Briones M.M.   Russell G.C.   Oliver R.A.   Tami C.   Taboga O.   Carrillo E.   Palma E.L.   Sobrino F.   Glass E.J.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1167-1171

Elsevier

Access to resources Recommend Favorite